Pro Medicus (OTCMKTS:PMCUF) Shares Gap Down – Time to Sell?

Pro Medicus Limited (OTCMKTS:PMCUFGet Free Report)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $134.8044, but opened at $125.90. Pro Medicus shares last traded at $125.90, with a volume of 10 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group cut shares of Pro Medicus from a “buy” rating to a “hold” rating in a report on Wednesday, July 8th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Pro Medicus has an average rating of “Hold” and a consensus target price of $155.00.

View Our Latest Stock Report on PMCUF

Pro Medicus Trading Down 3.8%

The firm has a market capitalization of $13.15 billion and a price-to-earnings ratio of 9,666.67. The company has a fifty day moving average price of $116.44 and a 200-day moving average price of $107.60.

About Pro Medicus

(Get Free Report)

Pro Medicus Limited is an Australia?based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.

See Also

Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.